Lv5
1340 积分 2023-11-14 加入
Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
16天前
已完结
SHR-1918, A Monoclonal Antibody Against Angiopoietin-Like 3, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
19天前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
19天前
已完结
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis
1个月前
已完结
Angiopoietin-like 3 in lipoprotein metabolism
1个月前
已完结
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
1个月前
已完结
Inhibition of IL‐6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer
1个月前
已完结
Interleukin-6, a mental cytokine
2个月前
已完结
The relationship between plasma interleukin-6 and cognition based on curve correlation in drug-naïve patients with major depressive disorder
2个月前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
2个月前
已完结
皖公网安备34019202002308
